<DOC>
	<DOC>NCT02642679</DOC>
	<brief_summary>The purpose of this single center, prospective case series is to evaluate the effective management of split-thickness skin graft donor site wounds using Opticell Ag (Chitosan-based dressing).</brief_summary>
	<brief_title>Evaluation of Opticell Ag on Split-Thickness Skin Graft Donor Sites in Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Chitosan</mesh_term>
	<criteria>Inpatient status at study site Subject must be receiving a splitthickness skin graft (STSG) Wounds must not exceed 10% total body surface area (TBSA) Any donor site Ability to comply with necessary wound care/follow up Subject is pregnant Subject has been diagnosed with Diabetes Subject is a smoker Subject takes steroids Subject is sensitive and/or allergic to shellfish and/or silver Wounds that exceed 10% total body surface area (TBSA) Inability to comply with necessary wound care/follow up</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Split-thickness skin graft, donor site, chitosan, dressing</keyword>
</DOC>